Covid-19 and autoimmunity

M Ehrenfeld, A Tincani, L Andreoli, M Cattalini… - Autoimmunity …, 2020 - Elsevier
Though the exact etiology of autoimmune diseases still remains unknown, there are various
factors which are believed to contribute to the emergence of an autoimmune disease in a …

Antiphospholipid syndrome

K Schreiber, S Sciascia, PG De Groot… - Nature reviews Disease …, 2018 - nature.com
Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence
of antiphospholipid antibodies, such as lupus anticoagulant, anticardiolipin antibodies and …

The cutaneous spectrum of lupus erythematosus

S Ribero, S Sciascia, L Borradori, D Lipsker - Clinical reviews in allergy & …, 2017 - Springer
Systemic lupus erythematosus is a complex autoimmune disease with a wide spectrum of
clinical and immunopathological features. Cutaneous and articular manifestations are the …

Biological markers of high risk of thrombotic recurrence in patients with antiphospholipid syndrome: a literature review

M Lambert, A Brodovitch, JL Mège, D Bertin… - Autoimmunity …, 2024 - Elsevier
Objectives This review aims to identify biological markers of the risk of recurrence of
thrombotic and/or obstetric events in patients with antiphospholipid syndrome (APS) …

Autoantibodies and autoimmune disorders in SARS-CoV-2 infection: pathogenicity and immune regulation

T Darmarajan, KR Paudel, M Candasamy… - … Science and Pollution …, 2022 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease associated with the
respiratory system caused by the SARS-CoV-2 virus. The aim of this review article is to …

Refractory obstetrical antiphospholipid syndrome: features, treatment and outcome in a European multicenter retrospective study

A Mekinian, J Alijotas-Reig, F Carrat… - Autoimmunity …, 2017 - Elsevier
Aim To describe the consecutive pregnancy outcome and treatment in refractory obstetrical
antiphospholipid syndrome (APS). Methods Retrospective multicenter open-labelled study …

Relationship between gender differences and clinical outcome in patients with the antiphospholipid syndrome

S Truglia, A Capozzi, S Mancuso… - Frontiers in …, 2022 - frontiersin.org
Antiphospholipid syndrome (APS), characterized by artherial and/or venous thrombosis,
pregnancy morbidity and “antiphospholipid” antibodies (aPLs), is more common in women …

The relevance, predictability, and utility of annexin A5 for human physiopathology

J **g - International Journal of Molecular Sciences, 2024 - mdpi.com
As an important functional protein molecule in the human body, human annexin A5
(hAnxA5) is widely found in human cells and body fluids. hAnxA5, the smallest type of …

Antiphospholipid syndrome: state of the art of clinical management

L Depietri, MR Veropalumbo, MC Leone… - … Drugs and Therapy, 2023 - Springer
Antiphospholipid syndrome (APS) is a systemic autoimmune disorder clinically
characterized by recurrent arterial and venous thrombosis and/or pregnancy morbidity in the …

Antiphospholipid syndrome: Diagnosis and management in the obstetric patient

E Arslan, DW Branch - Best practice & research Clinical obstetrics & …, 2020 - Elsevier
Antiphospholipid syndrome (APS) is a rare condition clinically characterized by thrombotic
events or pregnancy complications and confirmed by one or more repeatedly positive …